Skip to content

Impact of Family History and Decision Support on High-risk Cancer Screening

Impact of Family History and Decision Support on High-risk Cancer Screening

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02247336
Enrollment
505
Registered
2014-09-25
Start date
2017-08-01
Completion date
2020-07-13
Last updated
2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

colorectal cancer, early detection of cancer

Brief summary

Family health history can help identify patients at higher than average risk for disease. There is no standardized system for collecting and updating family health history, using this information to determine a patient's disease risk level, and providing screening recommendations to patients and providers. Patients will enter their family health history into MeTree, a family history software program. The program will produce screening recommendations tailored to the patient's family health history. The investigators will examine whether this process increases physician referrals for, and patient uptake of, guideline-recommended screening for colorectal cancer.

Detailed description

Eligible patients are aged 40-65 years, enrolled in primary care, do not have a personal history of colorectal cancer, and have some knowledge of family health history. In Aim 1, a retrospective chart review will be conducted to determine the baseline rate of documenting family health history of colorectal cancer in the medical record for patients enrolled in the Aim 2 randomized trial. In Aim 2, consented patients will be randomized to provide patient-entered family health history and receive patient and provider decision support at enrollment or 12 months later (wait-list control). The primary outcome is risk-appropriate CRC screening/surveillance referral for patients 12 months post-enrollment. Secondary outcomes include patient uptake of recommendations and referral for genetic consultation 12 months post-enrollment. In Aim 3, qualitative interviews will be conducted with physicians and clinic leaders; data will be analyzed using conventional content analysis. In Aim 4, data will be obtained from the administrative databases and patient medical records to conduct a budget impact analysis.

Interventions

BEHAVIORALFamily health history platform (MeTree)

Participants will enter their family health history information into a family health history platform, patients and providers will receive a decision support document and pedigree

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

Primary care provider inclusion criteria: * primary care physician, * physician assistant, or nurse practitioner; * at least one half-day of primary care clinic per week. Patient inclusion criteria: * assigned to an enrolled PCP; * English as preferred language; * no plans to relocate or leave the VA system in the next 12 months; * at least one primary care appointment in the 18 months prior to enrollment; * upcoming PCP appointment with assigned PCP; * aged 40-64 years; no previous history of colorectal cancer or adenomatous polyps or inflammatory bowel disease; * no endoscopy within previous 3 years; some knowledge of family health history

Exclusion criteria

n/a (contained within inclusion criteria)

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients With Provider Referral for Risk-appropriate Colorectal Cancer Screening12 monthsPatients who receive guideline-recommended referral consistent with the risk stratum determined by the family health history platform.

Secondary

MeasureTime frameDescription
Number of Participants Who Received Recommended Colorectal Cancer Screening12 monthsAmong patients who received a referral, the percentage who received recommended colorectal cancer screening.
Number of Patients Who Received Referral for Genetic Consultation12 monthsOf patients who received a recommendation for genetic consultation based on the family history platform, the percentage who received a referral for genetic consultation.

Countries

United States

Participant flow

Participants by arm

ArmCount
Immediate
Patients will complete MeTree at enrollment MeTree: Participants will enter their family health history information into MeTree, patients and providers will receive a decision support document and pedigree
252
Delayed
Patients will complete MeTree 12 months following enrollment MeTree: Participants will enter their family health history information into MeTree, patients and providers will receive a decision support document and pedigree
253
Total505

Baseline characteristics

CharacteristicImmediateDelayedTotal
Age, Continuous51.6 years
STANDARD_DEVIATION 7.1
51.3 years
STANDARD_DEVIATION 7.7
51.4 years
STANDARD_DEVIATION 7.2
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants12 Participants21 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
242 Participants240 Participants482 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants2 Participants
Ever had a colonoscopy or sigmoidoscopy101 Participants97 Participants198 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants2 Participants4 Participants
Race (NIH/OMB)
Asian
0 Participants3 Participants3 Participants
Race (NIH/OMB)
Black or African American
77 Participants87 Participants164 Participants
Race (NIH/OMB)
More than one race
9 Participants12 Participants21 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
7 Participants9 Participants16 Participants
Race (NIH/OMB)
White
156 Participants139 Participants295 Participants
Sex: Female, Male
Female
56 Participants28 Participants84 Participants
Sex: Female, Male
Male
196 Participants225 Participants421 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 2520 / 253
other
Total, other adverse events
0 / 2520 / 253
serious
Total, serious adverse events
0 / 2520 / 253

Outcome results

Primary

Number of Patients With Provider Referral for Risk-appropriate Colorectal Cancer Screening

Patients who receive guideline-recommended referral consistent with the risk stratum determined by the family health history platform.

Time frame: 12 months

Population: The analysis sample is the number of patients who completed the family health history assessment, as risk level was necessary to determine risk-appropriate referrals.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ImmediateNumber of Patients With Provider Referral for Risk-appropriate Colorectal Cancer Screening219 Participants
DelayedNumber of Patients With Provider Referral for Risk-appropriate Colorectal Cancer Screening232 Participants
Comparison: Using alpha=0.05, 80% power, and a risk-appropriate screening referral rate for the delayed arm ranging from 60% to 70%, n = 250 participants with a completed a family health history assessment per arm with 40 providers was needed to detect differences between arms in appropriate referral ranging from 12% to 13.2%. Sample size calculations accounted for provider clustering using an intra-class correlation coefficient of 0.02 to adjust variance for a Z-test of the difference of two proportions.p-value: 0.1695% CI: [0.4, 1.2]Regression, Logistic
Secondary

Number of Participants Who Received Recommended Colorectal Cancer Screening

Among patients who received a referral, the percentage who received recommended colorectal cancer screening.

Time frame: 12 months

Population: Analytic sample is participants who had a referral for colorectal cancer screening

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ImmediateNumber of Participants Who Received Recommended Colorectal Cancer Screening55 Participants
DelayedNumber of Participants Who Received Recommended Colorectal Cancer Screening68 Participants
p-value: 0.2395% CI: [0.04, 1.2]Regression, Logistic
Secondary

Number of Patients Who Received Referral for Genetic Consultation

Of patients who received a recommendation for genetic consultation based on the family history platform, the percentage who received a referral for genetic consultation.

Time frame: 12 months

Population: Subgroup of veterans who received a recommendation for genetic counseling from the family health history platform

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ImmediateNumber of Patients Who Received Referral for Genetic Consultation1 Participants
DelayedNumber of Patients Who Received Referral for Genetic Consultation1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026